Skip to main content
. 2020 May 6;9(5):1357. doi: 10.3390/jcm9051357

Table 1.

Clinical characteristics, in-hospital treatments, complications, outcomes, and resource utilization in heat stroke patients.

Total Acute Myocardial Infarction No Acute Myocardial Infarction p-Value
Clinical characteristics
N (%) 3372 225 (6.7) 3147 (93.3)
Age (years) 55 ± 22 62 ± 20 54 ± 22 <0.001
<20 218 (6.5) 4 (1.8) 214 (6.8) <0.001
20–39 654 (19.4) 27 (12.0) 627 (19.9)
40–59 1034 (30.7) 69 (30.7) 965 (30.7)
60–79 900 (26.7) 65 (28.9) 835 (26.6)
≥80 564 (16.7) 60 (26.7) 504 (16.0)
Sex <0.001
Male 2478 (73.5) 135 (60.0) 2343 (74.5)
Female 894 (26.5%) 90 (40.0) 804 (25.5%)
Race 0.67
Caucasian 1883 (55.8) 118 (52.4) 1765 (56.1)
African American 496 (14.7) 33 (14.7) 463 (14.7)
Hispanic 428 (12.7) 33 (14.7) 395 (12.6)
Other 565 (16.8) 41 (18.2) 524 (16.7)
Smoking 604 (17.9) 22 (9.8) 582 (18.5) 0.001
Alcohol drinking 270 (8.0) 13 (5.8) 257 (8.2) 0.20
Obesity 233 (6.9) 26 (11.6) 207 (6.6) 0.004
Diabetes Mellitus 562 (16.7) 56 (24.9) 506 (16.1) 0.001
Hypertension 1255 (37.2) 112 (49.8) 1143 (36.3) <0.001
Dyslipidemia 495 (14.7) 41 (18.2) 454 (14.4) 0.12
Hypothyroidism 196 (5.8) 7 (3.1) 189 (6.0) 0.07
Chronic kidney disease 201 (6.0) 24 (10.7) 177 (5.6) 0.002
Coronary artery disease 389 (11.5) 37 (16.4) 352 (11.2) 0.02
Congestive heart failure 216 (6.4) 23 (10.2) 193 (6.1) 0.02
Atrial flutter/fibrillation 251 (7.4) 22 (9.8) 229 (7.3) 0.17
Treatment
Invasive mechanical ventilation 686 (20.3) 94 (41.8) 592 (18.8) <0.001
Blood component transfusion 169 (5.0) 35 (15.6) 134 (4.3) <0.001
Renal replacement therapy 75 (2.2) 11 (4.9) 64 (2.0) 0.005
Coronary angiogram ± primary coronary intervention 18 (0.5) 18 (8.0%) 0 (0) N/A
Complication and outcomes
Hyponatremia 293 (8.7) 14 (6.2) 279 (8.9) 0.17
Hypernatremia 183 (5.4) 16 (7.1) 167 (5.3) 0.25
Hypokalemia 500 (14.8) 32 (14.2) 468 (14.9) 0.79
Hyperkalemia 134 (4.0) 10 (4.4) 124 (3.9) 0.71
Hypocalcemia 73 (2.2) 3 (1.3) 70 (2.2) 0.38
Hypercalcemia 37 (1.1) 1 (0.4) 36 (1.1) 0.33
Rhabdomyolysis 1049 (31.1) 83 (36.9) 966 (30.7) 0.05
Metabolic acidosis 472 (14.0) 50 (22.2) 422 (13.4) <0.001
Metabolic alkalosis 29 (0.9) 4 (1.8) 25 (0.8) 0.12
Sepsis 149 (4.4) 29 (12.9) 120 (3.8) <0.001
Gastrointestinal bleeding 54 (1.6) 16 (7.1) 38 (1.2) <0.001
Ventricular arrhythmia/cardiac arrest 95 (2.8) 16 (7.1) 79 (2.5) 0.001
Renal failure 1226 (36.4) 103 (45.8) 1123 (35.7) 0.002
Respiratory failure 550 (16.3) 87 (38.7) 463 (14.7) <0.001
Circulatory failure 393 (11.7) 40 (17.8) 353 (11.2) 0.003
Liver failure 196 (5.8) 35 (15.6) 161 (5.1) <0.001
Neurological failure 651 (19.3) 68 (30.2) 583 (18.5) <0.001
Hematological failure 449 (13.3) 60 (26.7) 389 (12.4) <0.001
In-hospital mortality 168 (5.0) 35 (15.6) 133 (4.2) <0.001
Resource utilization
Length of hospital stay (days) 4.3 ± 7.0 8.0 ± 13.4 4.0 ± 6.2 <0.001
Hospitalization cost ($) 35,335 ± 72,085 72,444 ± 117,246 32,757 ± 67,112 <0.001

Continuous variables were reported as mean ± standard deviation; categorical variables as counts (percentages).